Nrf2 induces fibroblast growth factor 21 in diabetic mice

Genes to Cells

Volumn 19, Issue 12, 2014, Pages 864-878

  Furusawa, Yuki ^a,b   Uruno, Akira ^a   Yagishita, Yoko ^a   Higashi, Chika ^a,b   Yamamoto, Masayuki ^a  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b MOCHIDA PHARMACEUTICAL CO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

1-(2-CYANO-3,12-DIOXOOLEANA-1,9-DIEN-28-OYL) IMIDAZOLE; BIOLOGICAL MARKER; CYTOSKELETON PROTEIN; FIBROBLAST GROWTH FACTOR; FIBROBLAST GROWTH FACTOR 21; IMIDAZOLE DERIVATIVE; KEAP1 PROTEIN, MOUSE; NFE2L2 PROTEIN, MOUSE; OLEANOLIC ACID; SIGNAL TRANSDUCING ADAPTOR PROTEIN; TRANSCRIPTION FACTOR NRF2;

ANALOGS AND DERIVATIVES; ANIMAL; BIOSYNTHESIS; DRUG EFFECTS; EXPERIMENTAL DIABETES MELLITUS; GENE SILENCING; GENETICS; KNOCKOUT MOUSE; LIPID METABOLISM; LIVER; METABOLISM; MOUSE; OBESITY; PATHOLOGY;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; BIOLOGICAL MARKERS; CYTOSKELETAL PROTEINS; DIABETES MELLITUS, EXPERIMENTAL; FIBROBLAST GROWTH FACTORS; GENE KNOCKDOWN TECHNIQUES; IMIDAZOLES; LIPID METABOLISM; LIVER; MICE; MICE, KNOCKOUT; NF-E2-RELATED FACTOR 2; OBESITY; OLEANOLIC ACID;

EID: 84910681905     PISSN: 13569597     EISSN: 13652443     Source Type: Journal    
DOI: 10.1111/gtc.12186     Document Type: Article

References (56)

1. Aleksunes, L.M., Reisman, S.A., Yeager, R.L., Goedken, M.J. & Klaassen, C.D. (2010) Nuclear factor erythroid 2-related factor 2 deletion impairs glucose tolerance and exacerbates hyperglycemia in type 1 diabetic mice. J. Pharmacol. Exp. Ther. 333, 140-151.
2. Badman, M.K., Pissios, P., Kennedy, A.R., Koukos, G., Flier, J.S. & Maratos-Flier, E. (2007) Hepatic fibroblast growth factor 21 is regulated by PPARα and is a key mediator of hepatic lipid metabolism in ketotic states. Cell Metab. 5, 426-437.
3. Chartoumpekis, D.V., Ziros, P.G., Psyrogiannis, A.I., Papavassiliou, A.G., Kyriazopoulou, V.E., Sykiotis, G.P. & Habeos, I.G. (2011) Nrf2 represses FGF21 during long-term high-fat diet-induced obesity in mice. Diabetes 60, 2465-2473.
4. Coskun, T., Bina, H.A., Schneider, M.A., Dunbar, J.D., Hu, C.C., Chen, Y., Moller, D.E. & Kharitonenkov, A. (2008) Fibroblast growth factor 21 corrects obesity in mice. Endocrinology 149, 6018-6027.
5. Ding, X., Boney-Montoya, J., Owen, B.M., Bookout, A.L., Coate, K.C., Mangelsdorf, D.J. & Kliewer, S.A. (2012) βKlotho is required for fibroblast growth factor 21 effects on growth and metabolism. Cell Metab. 16, 387-393.
6. Dushay, J., Chui, P.C., Gopalakrishnan, G.S., Varela-Rey, M., Crawley, M., Fisher, F.M., Badman, M.K., Martinez-Chantar, M.L. & Maratos-Flier, E. (2010) Increased fibroblast growth factor 21 in obesity and nonalcoholic fatty liver disease. Gastroenterology 139, 456-463.
7. Dutchak, P.A., Katafuchi, T., Bookout, A.L., Choi, J.H., Yu, R.T., Mangelsdorf, D.J. & Kliewer, S.A. (2012) Fibroblast growth factor-21 regulates PPARγ activity and the antidiabetic actions of thiazolidinediones. Cell 148, 556-567.
8. Fisher, F.M., Kleiner, S., Douris, N., Fox, E.C., Mepani, R.J., Verdeguer, F., Wu, J., Kharitonenkov, A., Flier, J.S., Maratos-Flier, E. & Spiegelman, B.M. (2012) FGF21 regulates PGC-1α and browning of white adipose tissues in adaptive thermogenesis. Genes Dev. 26, 271-281.
9. Fon Tacer, K., Bookout, A.L., Ding, X., Kurosu, H., John, G.B., Wang, L., Goetz, R., Mohammadi, M., Kuro-o, M., Mangelsdorf, D.J. & Kliewer, S.A. (2010) Research resource: comprehensive expression atlas of the fibroblast growth factor system in adult mouse. Mol. Endocrinol. 24, 2050-2064.
10. Frank, R. & Hargreaves, R. (2003) Clinical biomarkers in drug discovery and development. Nat. Rev. Drug Discov. 2, 566-580.
11. Gaich, G., Chien, J.Y., Fu, H., Glass, L.C., Deeg, M.A., Holland, W.L., Kharitonenkov, A., Bumol, T., Schilske, H.K. & Moller, D.E. (2013) The effects of LY2405319, an FGF21 analog, in obese human subjects with type 2 diabetes. Cell Metab. 18, 333-340.
12. Ge, X., Chen, C., Hui, X., Wang, Y., Lam, K.S. & Xu, A. (2011) Fibroblast growth factor 21 induces glucose transporter-1 expression through activation of the serum response factor/Ets-like protein-1 in adipocytes. J. Biol. Chem. 286, 34533-34541.
13. Hiramoto, K., Satoh, H., Suzuki, T., Moriguchi, T., Pi, J., Shimosegawa, T. & Yamamoto, M. (2014) Myeloid lineage-specific deletion of antioxidant system enhances tumor metastasis. Cancer Prev. Res. (Phila.) 7, 835-844.
14. Hirotsu, Y., Higashi, C., Fukutomi, T., Katsuoka, F., Tsujita, T., Yagishita, Y., Matsuyama, Y., Motohashi, H., Uruno, A. & Yamamoto, M. (2014) Transcription factor NF-E2-related factor 1 impairs glucose metabolism in mice. Genes Cells 19, 650-665.
15. Hirotsu, Y., Katsuoka, F., Funayama, R., Nagashima, T., Nishida, Y., Nakayama, K., Engel, J.D. & Yamamoto, M. (2012) Nrf2-MafG heterodimers contribute globally to antioxidant and metabolic networks. Nucleic Acids Res. 40, 10228-10239.
16. Iizuka, K., Takeda, J. & Horikawa, Y. (2009) Glucose induces FGF21 mRNA expression through ChREBP activation in rat hepatocytes. FEBS Lett. 583, 2882-2886.
17. Inagaki, T., Dutchak, P., Zhao, G. et al. (2007) Endocrine regulation of the fasting response by PPARα-mediated induction of fibroblast growth factor 21. Cell Metab. 5, 415-425.
18. Ishii, T., Itoh, K., Takahashi, S., Sato, H., Yanagawa, T., Katoh, Y., Bannai, S. & Yamamoto, M. (2000) Transcription factor Nrf2 coordinately regulates a group of oxidative stress-inducible genes in macrophages. J. Biol. Chem. 275, 16023-16029.
19. Ito, S., Kinoshita, S., Shiraishi, N., Nakagawa, S., Sekine, S., Fujimori, T. & Nabeshima, Y.I. (2000) Molecular cloning and expression analyses of mouse βklotho, which encodes a novel Klotho family protein. Mech. Dev. 98, 115-119.
20. Itoh, K., Chiba, T., Takahashi, S., Ishii, T., Igarashi, K., Katoh, Y., Oyake, T., Hayashi, N., Satoh, K., Hatayama, I., Yamamoto, M. & Nabeshima, Y. (1997) An Nrf2/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements. Biochem. Biophys. Res. Commun. 236, 313-322.
21. Itoh, K., Igarashi, K., Hayashi, N., Nishizawa, M. & Yamamoto, M. (1995) Cloning and characterization of a novel erythroid cell-derived CNC family transcription factor heterodimerizing with the small Maf family proteins. Mol. Cell. Biol. 15, 4184-4193.
22. Itoh, K., Wakabayashi, N., Katoh, Y., Ishii, T., Igarashi, K., Engel, J.D. & Yamamoto, M. (1999) Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain. Genes Dev. 13, 76-86.
23. Kharitonenkov, A., Shiyanova, T.L., Koester, A. et al. (2005) FGF-21 as a novel metabolic regulator. J. Clin. Invest. 115, 1627-1635.
24. Kharitonenkov, A., Wroblewski, V.J., Koester, A., Chen, Y.F., Clutinger, C.K., Tigno, X.T., Hansen, B.C., Shanafelt, A.B. & Etgen, G.J. (2007) The metabolic state of diabetic monkeys is regulated by fibroblast growth factor-21. Endocrinology 148, 774-781.
25. Kobayashi, A., Kang, M.I., Okawa, H., Ohtsuji, M., Zenke, Y., Chiba, T., Igarashi, K. & Yamamoto, M. (2004) Oxidative stress sensor Keap1 functions as an adaptor for Cul3-based E3 ligase to regulate proteasomal degradation of Nrf2. Mol. Cell. Biol. 24, 7130-7139.
26. Kurosu, H., Choi, M., Ogawa, Y., Dickson, A.S., Goetz, R., Eliseenkova, A.V., Mohammadi, M., Rosenblatt, K.P., Kliewer, S.A. & Kuro-o, M. (2007) Tissue-specific expression of βKlotho and fibroblast growth factor (FGF) receptor isoforms determines metabolic activity of FGF19 and FGF21. J. Biol. Chem. 282, 26687-26695.
27. Lewin, D.A. & Weiner, M.P. (2004) Molecular biomarkers in drug development. Drug Discov. Today 9, 976-983.
28. Lundåsen, T., Hunt, M.C., Nilsson, L.M., Sanyal, S., Angelin, B., Alexson, S.E. & Rudling, M. (2007) PPARα is a key regulator of hepatic FGF21. Biochem. Biophys. Res. Commun. 360, 437-440.
29. Mashili, F.L., Austin, R.L., Deshmukh, A.S., Fritz, T., Caidahl, K., Bergdahl, K., Zierath, J.R., Chibalin, A.V., Moller, D.E., Kharitonenkov, A. & Krook, A. (2011) Direct effects of FGF21 on glucose uptake in human skeletal muscle: implications for type 2 diabetes and obesity. Diabetes Metab. Res. Rev. 27, 286-297.
30. Meher, A.K., Sharma, P.R., Lira, V.A., Yamamoto, M., Kensler, T.W., Yan, Z. & Leitinger, N. (2012) Nrf2 deficiency in myeloid cells is not sufficient to protect mice from high-fat diet-induced adipose tissue inflammation and insulin resistance. Free Radic. Biol. Med. 52, 1708-1715.
31. Mitsuishi, Y., Taguchi, K., Kawatani, Y., Shibata, T., Nukiwa, T., Aburatani, H., Yamamoto, M. & Motohashi, H. (2012) Nrf2 redirects glucose and glutamine into anabolic pathways in metabolic reprogramming. Cancer Cell 22, 66-79.
32. Moi, P., Chan, K., Asunis, I., Cao, A. & Kan, Y.W. (1994) Isolation of NF-E2-related factor 2 (Nrf2), a NF-E2-like basic leucine zipper transcriptional activator that binds to the tandem NF-E2/AP1 repeat of the β-globin locus control region. Proc. Natl Acad. Sci. USA 91, 9926-9930.
33. Motohashi, H. & Yamamoto, M. (2004) Nrf2-Keap1 defines a physiologically important stress response mechanism. Trends Mol. Med. 10, 549-557.
34. Muise, E.S., Azzolina, B., Kuo, D.W., El-Sherbeini, M., Tan, Y., Yuan, X., Mu, J., Thompson, J.R., Berger, J.P. & Wong, K.K. (2008) Adipose fibroblast growth factor 21 is up-regulated by peroxisome proliferator-activated receptor γ and altered metabolic states. Mol. Pharmacol. 74, 403-412.
35. Nishimura, T., Nakatake, Y., Konishi, M. & Itoh, N. (2000) Identification of a novel FGF, FGF-21, preferentially expressed in the liver. Biochim. Biophys. Acta 1492, 203-206.
36. Pi, J., Leung, L., Xue, P., Wang, W., Hou, Y., Liu, D., Yehuda-Shnaidman, E., Lee, C., Lau, J., Kurtz, T.W. & Chan, J.Y. (2010) Deficiency in the nuclear factor E2-related factor-2 transcription factor results in impaired adipogenesis and protects against diet-induced obesity. J. Biol. Chem. 285, 9292-9300.
37. Saha, P.K., Reddy, V.T., Konopleva, M., Andreeff, M. & Chan, L. (2010) The triterpenoid 2-cyano-3, 12-dioxooleana-1, 9-dien-28-oic-acid methyl ester has potent anti-diabetic effects in diet-induced diabetic mice and Lepr(db/db) mice. J. Biol. Chem. 285, 40581-40592.
38. Shin, S., Wakabayashi, J., Yates, M.S., Wakabayashi, N., Dolan, P.M., Aja, S., Liby, K.T., Sporn, M.B., Yamamoto, M. & Kensler, T.W. (2009) Role of Nrf2 in prevention of high-fat diet-induced obesity by synthetic triterpenoid CDDO-imidazolide. Eur. J. Pharmacol. 620, 138-144.
39. Taguchi, K., Maher, J.M., Suzuki, T., Kawatani, Y., Motohashi, H. & Yamamoto, M. (2010) Genetic analysis of cytoprotective functions supported by graded expression of Keap1. Mol. Cell. Biol. 30, 3016-3026.
40. Takaya, K., Suzuki, T., Motohashi, H., Onodera, K., Satomi, S., Kensler, T.W. & Yamamoto, M. (2012) Validation of the multiple sensor mechanism of the Keap1-Nrf2 system. Free Radic. Biol. Med. 53, 817-827.
41. Tong, K.I., Padmanabhan, B., Kobayashi, A., Shang, C., Hirotsu, Y., Yokoyama, S. & Yamamoto, M. (2007) Different electrostatic potentials define ETGE and DLG motifs as hinge and latch in oxidative stress response. Mol. Cell. Biol. 27, 7511-7521.
42. Uruno, A., Furusawa, Y., Yagishita, Y., Fukutomi, T., Muramatsu, H., Negishi, T., Sugawara, A., Kensler, T.W. & Yamamoto, M. (2013) The Keap1-Nrf2 system prevents onset of diabetes mellitus. Mol. Cell. Biol. 33, 2996-3010.
43. Uruno, A., Matsuda, K., Noguchi, N., Yoshikawa, T., Kudo, M., Satoh, F., Rainey, W.E., Hui, X.G., Akahira, J., Nakamura, Y., Sasano, H., Okamoto, H., Ito, S. & Sugawara, A. (2011a) Peroxisome proliferator-activated receptor-γ suppresses CYP11B2 expression and aldosterone production. J. Mol. Endocrinol. 46, 37-49.
44. Uruno, A. & Motohashi, H. (2011) The Keap1-Nrf2 system as an in vivo sensor for electrophiles. Nitric Oxide 25, 153-160.
45. Uruno, A., Noguchi, N., Matsuda, K., Nata, K., Yoshikawa, T., Chikamatsu, Y., Kagechika, H., Harigae, H., Ito, S., Okamoto, H. & Sugawara, A. (2011b) All-trans retinoic acid and a novel synthetic retinoid tamibarotene (Am 80) differentially regulate CD38 expression in human leukemia HL-60 cells: possible involvement of protein kinase C-δ. J. Leukoc. Biol. 90, 235-247.
46. Wente, W., Efanov, A.M., Brenner, M., Kharitonenkov, A., Köster, A., Sandusky, G.E., Sewing, S., Treinies, I., Zitzer, H. & Gromada, J. (2006) Fibroblast growth factor-21 improves pancreatic β-cell function and survival by activation of extracellular signal-regulated kinase 1/2 and Akt signaling pathways. Diabetes 55, 2470-2478.
47. Xu, J., Lloyd, D.J., Hale, C. et al. (2009) Fibroblast growth factor 21 reverses hepatic steatosis, increases energy expenditure, and improves insulin sensitivity in diet-induced obese mice. Diabetes 58, 250-259.
48. Xue, P., Hou, Y., Chen, Y., Yang, B., Fu, J., Zheng, H., Yarborough, K., Woods, C.G., Liu, D., Yamamoto, M., Zhang, Q., Andersen, M.E. & Pi, J. (2013) Adipose deficiency of Nrf2 in ob/ob mice results in severe metabolic syndrome. Diabetes 62, 845-854.
49. Yagishita, Y., Fukutomi, T., Sugawara, A., Kawamura, H., Takahashi, T., Pi, J., Uruno, A. & Yamamoto, M. (2014) Nrf2 protects pancreatic β-cells from oxidative and nitrosative stress in diabetic model mice. Diabetes 63, 605-618.
50. Yamamoto, T., Suzuki, T., Kobayashi, A., Wakabayashi, J., Maher, J., Motohashi, H. & Yamamoto, M. (2008) Physiological significance of reactive cysteine residues of Keap1 in determining Nrf2 activity. Mol. Cell. Biol. 28, 2758-2770.
51. Yamazaki, H., Katsuoka, F., Motohashi, H., Engel, J.D. & Yamamoto, M. (2012) Embryonic lethality and fetal liver apoptosis in mice lacking all three small Maf proteins. Mol. Cell. Biol. 32, 808-816.
52. Yates, M.S., Tauchi, M., Katsuoka, F., Flanders, K.C., Liby, K.T., Honda, T., Gribble, G.W., Johnson, D.A., Johnson, J.A., Burton, N.C., Guilarte, T.R., Yamamoto, M., Sporn, M.B. & Kensler, T.W. (2007) Pharmacodynamic characterization of chemopreventive triterpenoids as exceptionally potent inducers of Nrf2-regulated genes. Mol. Cancer Ther. 6, 154-162.
53. Ye, D., Wang, Y., Li, H., Jia, W., Man, K., Lo, C.M., Lam, K.S. & Xu, A. (2014) Fibroblast growth factor 21 protects against acetaminophen-induced hepatotoxicity by potentiating peroxisome proliferator-activated receptor coactivator protein-1a-mediated antioxidant capacity in mice. Hepatology 60, 977-989.
54. Zhang, D.D., Lo, S.C., Cross, J.V., Templeton, D.J. & Hannink, M. (2004) Keap1 is a redox-regulated substrate adaptor protein for a Cul3-dependent ubiquitin ligase complex. Mol. Cell. Biol. 24, 10941-10953.
55. Zhang, J., Kang, M.J., Kim, M.J., Kim, M.E., Song, J.H., Lee, Y.M. & Kim, J.I. (2008a) Pancreatic lipase inhibitory activity of taraxacum officinale in vitro and in vivo. Nutr. Res. Pract. 2, 200-203.
56. Zhang, X., Yeung, D.C., Karpisek, M., Stejskal, D., Zhou, Z.G., Liu, F., Wong, R.L., Chow, W.S., Tso, A.W., Lam, K.S. & Xu, A. (2008b) Serum FGF21 levels are increased in obesity and are independently associated with the metabolic syndrome in humans. Diabetes 57, 1246-1253.